Leadership Overview
Neuland Laboratories has 7 executives leading key functions including strategy, information technology, operations, human resources, medical affairs, marketing, and business development.
Driven by innovation, Neuland Laboratories is dedicated to advancing drug development and cGMP manufacturing of APIs, leveraging strong process chemistry in regulatory environments to provide reliable solutions to the global pharmaceutical industry.
Driven by innovation, Neuland Laboratories is dedicated to advancing drug development and cGMP manufacturing of APIs, leveraging strong process chemistry in regulatory environments to provide reliable solutions to the global pharmaceutical industry.
Leadership Roles at Neuland Laboratories
Saharsh Davuluri - Chief Executive Officer & Managing Director
Saharsh Davuluri, the Chief Executive Officer & Managing Director at Neuland Laboratories, directs the company's overall strategic vision and operational execution. Davuluri guides Neuland's commitment to strong process chemistry within a stringent regulatory framework, ensuring the acceleration of drug development and cGMP manufacturing of active pharmaceutical ingredients (APIs). This leadership role involves fostering innovation across scientific and technical teams, enabling the delivery of reliable solutions to the global pharmaceutical sector. Saharsh Davuluri's oversight extends to driving the company's growth trajectory and maintaining its position as an end-to-end solution provider for chemistry-related services. The Chief Executive Officer & Managing Director ensures alignment with market demands and regulatory compliance, solidifying Neuland's reputation for excellence in API manufacturing.
Shashank Mahashabde - Contract Manufacturing President, Business Development
Shashank Mahashabde, the Contract Manufacturing President, Business Development at Neuland Laboratories, spearheads the expansion of contract manufacturing services and cultivates strategic partnerships. Mahashabde drives initiatives to enhance Neuland's capabilities in chemistry-related services and cGMP manufacturing of APIs, focusing on client acquisition and retention. This leadership position is crucial for extending Neuland Laboratories' reach as a comprehensive solution provider to the global pharmaceutical industry. The Contract Manufacturing President, Business Development identifies new market opportunities and strengthens existing client relationships, ensuring alignment with the company's growth objectives. Shashank Mahashabde's focus on business development and operational excellence supports Neuland's mission to accelerate drug development and deliver high-quality APIs.
Ajitabh Singh - Chief Information Officer
Ajitabh Singh, the Chief Information Officer at Neuland Laboratories, architects the company's technology infrastructure and digital strategy. Singh ensures that information systems effectively support Neuland's core competencies in process chemistry and cGMP manufacturing of APIs. This involves implementing robust IT solutions that enhance operational efficiency and data security across the organization. The Chief Information Officer's responsibilities include overseeing the integration of advanced technologies to streamline drug development processes and facilitate reliable service delivery to global pharmaceutical clients. Ajitabh Singh drives the digital transformation initiatives, ensuring that Neuland Laboratories maintains a competitive edge through technological innovation and secure data management, supporting the company's mission in the pharmaceutical industry.
Raja Shekar - Deputy Manager, Material Planning & Chief Marketing Officer
Raja Shekar, the Deputy Manager, Material Planning & Chief Marketing Officer at Neuland Laboratories, manages critical aspects of material flow and market outreach. Shekar optimizes the planning and procurement of raw materials essential for the cGMP manufacturing of APIs, ensuring uninterrupted production cycles. Concurrently, as Chief Marketing Officer, Raja Shekar develops and executes strategies to enhance Neuland's market presence and communicate its value proposition as an end-to-end solution provider. This dual role requires a deep understanding of both operational logistics and market dynamics within the pharmaceutical industry. Raja Shekar's efforts focus on aligning material availability with production demands and expanding the company's reach to new clients and markets, reinforcing Neuland Laboratories' position in API manufacturing.
Hemchandra Peruvelli - Chief Human Resources Officer
Hemchandra Peruvelli, the Chief Human Resources Officer at Neuland Laboratories, cultivates a high-performance culture essential for scientific and technical excellence. Peruvelli oversees talent acquisition, development, and retention strategies, ensuring Neuland Laboratories possesses the skilled workforce required for advanced process chemistry and regulatory-compliant API manufacturing. This leadership function is critical in supporting the company's mission to provide reliable solutions to the global pharmaceutical industry. The Chief Human Resources Officer drives initiatives that foster employee engagement and professional growth, aligning human capital with the company's strategic objectives. Hemchandra Peruvelli's focus remains on building a robust organizational structure that supports innovation and operational efficiency in the dynamic pharmaceutical landscape.
Adrian Monk - Chief Medical Officer
Adrian Monk, the Chief Medical Officer at Neuland Laboratories, provides critical medical and scientific insights that inform the company's strategic direction. Monk ensures that Neuland's API manufacturing processes and drug development services align with the highest standards of medical efficacy and patient safety. This role is pivotal in guiding the company's scientific teams and reinforcing its commitment to delivering reliable solutions within the pharmaceutical industry. The Chief Medical Officer's expertise contributes to the company's understanding of therapeutic areas and market needs, supporting the development of advanced pharmaceutical ingredients. Adrian Monk's guidance enhances Neuland Laboratories' capacity to serve the global pharmaceutical sector with scientifically sound and medically relevant offerings.
Dorothy Paul - Chief Marketing & Communications Officer
Dorothy Paul, the Chief Marketing & Communications Officer at Neuland Laboratories, shapes and disseminates the company's brand narrative and market positioning. Paul directs strategies that highlight Neuland's expertise in process chemistry and its role as an end-to-end solution provider for API manufacturing. This involves communicating the company's commitment to drug development acceleration and cGMP compliance to a global audience. The Chief Marketing & Communications Officer ensures consistent messaging across all platforms, reinforcing Neuland Laboratories' reputation for reliability and scientific rigor. Dorothy Paul's leadership drives engagement with stakeholders, enhancing market awareness and supporting business development objectives within the competitive pharmaceutical landscape.
Explore Leadership Teams in Manufacturing
Bayer is a global enterprise in the life science fields of healthcare and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. They have divisions in pharmaceuticals, crop science, animal health, and consumer health. Bayer is headquartered in Leverkusen, Germany.
Company Leadership LS
JL
BC
AbbVie Inc. is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines and health solutions that address some of the worlds most complex medical challenges. Headquartered in North Chicago, Illinois, the company operates internationally and focuses on advancing treatments that improve patient outcomes and overall quality of life. AbbVies scientific and commercial efforts are concentrated in several core therapeutic areas, including immunology, oncology, neuroscience, eye care, and medical aesthetics, along with other specialty areas where significant unmet medical needs exist. Through these focus areas, the company works to create therapies that help patients manage chronic, serious, and often life-altering diseases.
Company Leadership CS
MK
MB
MH
Cohance is a global Contract Development and Manufacturing Organization (CDMO) specializing in Antibody Drug Conjugates (ADCs), Nucleic Acid Chemistry, and Small Molecules. The company offers a wide range of services including API development, manufacturing, and clinical analytical services, aimed at accelerating the pipeline for pharmaceutical innovators. With a commitment to sustainability and quality, Cohance partners with clients to provide integrated solutions from discovery to commercial scale. Their expertise and innovative approach make them a trusted partner for complex molecule development and manufacturing needs.
Company Leadership
YD
SS
RS
Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO) offering end-to-end development and manufacturing solutions across the drug life cycle. We serve our customers through a globally integrated network of facilities in North America, Europe, and Asia. This enables us to offer a comprehensive range of services including drug discovery solutions, process & pharmaceutical development services, clinical trial supplies, commercial supply of APIs, and finished dosage forms. We also offer specialized services such as the development and manufacture of highly potent APIs, antibody-drug conjugations, sterile fill/finish, peptide products & services, and potent solid oral drug product. PPS also offers development and manufacturing services for biologics including vaccines, gene therapies, and monoclonal antibodies, made possible through Piramal Pharma Limited's investment in Yapan Bio Private Limited. Our track record as a trusted service provider with experience across varied technologies we believe makes us a partner of choice for innovator and generic companies worldwide.
Company Leadership SL
BC
RM
Frequently Asked Questions Regarding Neuland Laboratories Top Executives and Leadership Team
